Delivery Order SPE2DB20D3101-SPE2DB25FRGM1

Award Date 4/10/25
Potential Completion Date 4/11/25
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor. The $3,300.17 firm fixed price contract is for the supply of Clonidine Hydrochloride Extended-Release 0.1 mg tablets in 60-count bottles. The contract has an ultimate completion date of July 22, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor. The $4,806.91 firm fixed-price contract is for the provision of clonidine hydrochloride extended-release 0.1 mg tablets. The award is not associated with a set-aside program. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as the primary vehicle for...
Amerisourcebergen Drug Corp has received a firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical worth $1,144 to supply 60 clonidine hydrochloride extended release 0.1 mg tablets. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with all work to be completed by November 21, 2023. This order was awarded against an existing indefinite delivery contract held by Amerisourcebergen with no set-aside designation...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The contract is for the supply of Clonidine Hydrochloride Extended Release 0.17 mg Tablets in quantities of 30. The contract has a firm fixed price of $1,257.88 and a completion date of June 7, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including the Department of Defense...
This federal contract award, valued at $1,078.82, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of clonidine hydrochloride extended-release 0.17 mg tablets in 30-count packages. The contract has an ultimate completion date of May 8, 2024 and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp, a subsidiary of the larger Amerisourcebergen Corporation, is a major supplier of pharmaceutical...
This federal contract award is a delivery order made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of clonidine hydrochloride extended-release 0.17 mg tablets in 30-count packages. The award is valued at $1,089.14 and has a performance period that extends to July 29, 2024. This contract is a firm fixed-price delivery order awarded under a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $1,947.80 Delivery Order is for the supply of Clonidine Hydrochloride Extended-Release 0.1 mg tablets in 60-count bottles. This contract is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $2,139.57 firm-fixed-price delivery order is for the supply of clonidine hydrochloride extended-release 0.1 milligram tablets. The contract has an ultimate completion date of August 16, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the Department of...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,640.85, is for the delivery of clonidine hydrochloride extended-release 0.1 mg tablets. The contract is a firm fixed-price delivery order with a performance period ending on December 15, 2023. This contract award is not designated as a set-aside and appears to be part of a larger Indefinite...
This federal contract award from the Defense Logistics Agency Troop Support Medical (DLA) is a firm fixed price delivery order valued at $188.28 to Amerisourcebergen Drug Corp for the supply of 60 clonidine hydrochloride extended release 0.1 mg tablets. As a major division of Amerisourcebergen Corporation, Amerisourcebergen Drug Corp will deliver the generic pharmaceutical product from its facility in Conshohocken, Pennsylvania within the one day period of performance specified between August...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB25FRGM1
    Delivery Order

This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,419.89, is for the supply of clonidine hydrochloride extended-release 0.1 mg tablets in 60-count packages. The contract has an ultimate completion date of April 11, 2025. Amerisourcebergen Drug Corp is a for-profit organization headquartered in Conshohocken, Pennsylvania, and is a critical supplier of medical and pharmaceutical products to federal agencies, particularly the military healthcare system. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order is not designated as a set-aside contract.

Generated 7/17/25, 6:27 PM